![]() |
|
|
Vol. 296, Issue 3, 966-971, March 2001
Department of Pharmacology, University of North Texas Health
Science Center, Fort Worth, Texas (G.P., C.H., T.Y.); and Department of
Immunology, St. Paul Medical Center, Mary Kay Ash Institute for Cancer
Research, Dallas, Texas (A.D.)
Endothelin-1 (ET-1), a potent vasoconstrictor, lowers intraocular
pressure in mammals, either by enhancing the outflow of aqueous humor
(AH) via the trabecular meshwork and Schlemm's canal or by reducing AH
formation at the ciliary epithelium. Aqueous humor production occurs by
passive diffusion of water coupled with active transport of ions,
mainly involving Na+:K+:2Cl
cotransporter and Na+/K+-ATPase pump from
serosal to aqueous side. Presently, we have evaluated the effects of
ET-1 on Na+:K+:2Cl
cotransport
and Na+/K+-ATPase activity in HNPE cells using
86Rb+ uptake. ET-1 (100 pM-100 nM) decreased
mean 86Rb+ uptake by 15% during a 15-min
uptake period. ET-1's effect was not prevented by BQ610, an
ETA receptor antagonist, but was blocked by BQ788, an
ETB receptor antagonist. ET-1's effect was mimicked by
sarafotoxin, an ETB agonist. ET-1-induced reduction in
86Rb+ uptake was additive with bumetanide, a
selective inhibitor of Na+:K+:2Cl
cotransporter but not with ouabain, a selective inhibitor of the
Na+/K+-ATPase. ET-1 did not affect
iberiotoxin-sensitive maxi K+ channels. This suggests that
ET-1-induced reduction in 86Rb+ uptake is
mediated through the inhibition of the
Na+/K+-ATPase via an ETB-like
receptor. These findings are consistent with an ET-1 effect on active
ion transport activity in HNPE cells that could explain the reduction
in aqueous humor production and the lowering of intraocular pressure.